documents: FDA-2020-N-2196-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-N-2196-0001 FDA FDA-2020-N-2196 Allergan Pharmaceuticals International, Ltd.; Withdrawal of Approval of a New Drug Application for ASACOL (Mesalamine) Delayed-Release Tablets, 400 Milligrams Notice Withdrawal 2020-12-10T05:00:00Z 2020 12 2020-12-10T05:00:00Z   2020-12-10T12:59:11Z 2020-27082 0 0 0900006484995521

Links from other tables